Schizophrenia trials in Argentina

In Argentina 7 Also abroad 473

7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Where
Buenos Aires, Córdoba, Río Cuarto, Santiago del Estero
Age
18 years to 65 years
People
472 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07686263 · EU 2025-523664-20-00
Phase 3Taking people
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Where
Buenos Aires, Ciudad Autonoma de Buenos Aires, Ciudad Autónoma de Buenos Aires, Córdoba, Rosario
Age
55 years to 90 years
People
406 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00
Phase 2Taking people
A Study of Brenipatide in Adult Participants With Schizophrenia
Where
Buenos Aires, Caba, Córdoba, La Plata, Mendoza, Rosario
Age
18 years to 55 years
People
450 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07410507
Phase 2Taking people
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Where
Caba, Córdoba
Age
55 years to 90 years
People
300 worldwide
Run by
MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00
Phase 3Taking people
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Where
Buenos Aires
Age
18 years and over
People
400 worldwide
Run by
Newron Pharmaceuticals SPA
See details and how to joinNCT07184619
Phase 3Enrolling by invitation
Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
Where
Buenos Aires, Ciudad Autonoma de Buenos Aire, Córdoba, La Plata, Mendoza
Age
10 years to 17 years
People
236 worldwide
Run by
Alkermes, Inc.
See details and how to joinNCT04987229
Phase 3Taking people
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Where
Buenos Aires, Córdoba, La Plata, Mendoza
Age
10 years to 17 years
People
220 worldwide
Run by
Alkermes, Inc.
See details and how to joinNCT05303064